We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 623 results
  1. A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced cytokine storm is closely associated with coronavirus disease 2019 (COVID-19)...

    Lin **a, Lun-zhi Yuan, ... Wen Liu in Cellular & Molecular Immunology
    Article Open access 02 March 2023
  2. Severe polymicrobial and fungal periprosthetic osteomyelitis persisting after hip disarticulations treated with caspofungin in risk patients: a case series

    Background

    Periprosthetic fungal infections are considered rare and opportunistic infections. Treatment is difficult, and established standards do not...

    Andreas Enz, Silke Müller, ... Annett Klinder in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 31 December 2021
  3. Caspofungin Effects on Electrocardiogram of Mice: An Evaluation of Cardiac Safety

    Caspofungin is an echinocandin, exhibiting efficacy against most Candida species invasive infection. Its cardiotoxicity was reported in isolated rat...

    Danielle Cristiane Correa De Paula, Elaine Amaral Leite, ... Andrea Grabe-Guimarães in Cardiovascular Toxicology
    Article 26 August 2020
  4. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin

    Microorganisms are valuable resources for obtaining bioactive compounds, which have proven to be very useful in various domains, e.g., agriculture,...
    A. Bhama Mishra, P. Usha, V. Sabareesh in Fungi Bioactive Metabolites
    Chapter 2024
  5. Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans

    Purpose

    This study investigates how surfactants affect the in-vitro anti-infective efficacy of micafungin, caspofungin, anidulafungin, and...

    Alina Nussbaumer-Pröll, Peter Matzneller, ... Markus Zeitlinger in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 14 March 2024
  6. Strategies for Enhancing the Production of Echinocandin

    Fungi are well known for their ability to naturally produce a multitude of secondary metabolites (SMs) which act as a weapon of defense to protect...
    Hemlata Kumari, Shaurya Prakash, ... Antresh Kumar in Fungi Bioactive Metabolites
    Chapter 2024
  7. Analyzing Different Elution Profiles of Echinocandins In Vitro from the Antibiotic-Loaded Bone Cement Comprising Apatite or Polymethylmethacrylate

    Purpose

    This study aimed to examine the in vitro elution profiles of echinocandins, micafungin and caspofungin, obtained from antibiotic-loaded bone...

    Hiroki Hijikata, Tomoharu Mochizuki, ... Hiroyuki Kawashima in Journal of Medical and Biological Engineering
    Article 27 November 2021
  8. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study

    Background

    Dermatophytes have the ability to invade the keratin layer of humans and cause infections. The aims of this study were the accurate...

    Parisa Badiee, Tahereh Shokohi, ... Hadis Jafarian in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 20 February 2023
  9. Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies

    Background and aim

    Triazole, polyene, and echinocandin antifungal agents are extensively used to treat invasive fungal infections (IFIs); however, the...

    Huilan Zeng, Zhuman Wu, ... Jie Chen in BMC Cancer
    Article Open access 14 April 2021
  10. A Dual-Readout High-Throughput Screening Assay for Small Molecules Active Against Aspergillus Fumigatus

    Human fungal infections caused by molds have been on the rise in recent years. These infections have high mortality rates compared to other fungal...
    Sarah R. Beattie, Damian J. Krysan in Antifungal Drug Resistance
    Protocol 2023
  11. New Systemic Antifungal: Isavuconazole

    Invasive fungal infections have been increasing with the increased use of immunosuppressive drugs for the treatment of cancer, organ, stem cell and...
    Chapter 2023
  12. Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequencing technology

    Background

    Previous studies achieved low microbial detection rates in lymphoma patients with interstitial pneumonia (IP) after chemotherapy. However,...

    Dian **, **g Le, ... Wenxiu Shu in Infectious Agents and Cancer
    Article Open access 06 December 2023
  13. The prevalence of multidrug resistance in uropathogens of patients admitted in the intensive care unit of a tertiary care hospital

    Urinary tract infections (UTIs) are among the most common bacterial infections, posing significant public health challenges due to increasing...

    Shaista Ahmed, Neetu Shree, ... Mohd Ashif Khan in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 21 April 2024
  14. Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species

    Pulmonary aspergillosis is a life-threatening fungal infection with worldwide distribution. In the present study, clinical epidemiology of pulmonary...

    Zahra Salehi, Somayeh Sharifynia, ... Mehdi Razzaghi-Abyaneh in European Journal of Clinical Microbiology & Infectious Diseases
    Article 05 May 2023
  15. Antifungal

    Antifungal classification: 1. Polyenes. (a) Amphotericin B; 2. Flucytosine; 3. Triazoles: Triazoles are heterocyclic compounds, having a...
    Suman Sokhal, Navdeep Sokhal, Vasudha Singhal in Pharmacology in Clinical Neurosciences
    Chapter 2020
  16. The first report of Apiotrichum mycotoxinivorans isolation from human cerebrospinal fluid

    Fungal infections due to Apiotrichum mycotoxinivorans are clinically rare. Here, we report a case of invasive blood and cerebrospinal fluid infection...

    **uyun Li, Dong Wang, ... Shifu Wang in European Journal of Clinical Microbiology & Infectious Diseases
    Article 16 December 2023
  17. New Antifungal Drugs: Discovery and Therapeutic Potential

    There has been an increase in invasive fungal infections, which are a universal problem due to the longer average lifespan, the number of...
    Francisca Vicente, Fernando Reyes, Olga Genilloud in Fungi Bioactive Metabolites
    Chapter 2024
  18. Clinical characteristics and prognostic risk factors of candidemia in non-neutropenic patients: a retrospective cohort study

    This study aimed to determine the clinical characteristics and the prognostic risk factors in non-neutropenic patients with candidemia. Data were...

    Fengqi Liu, Xue** Shao, ... Gensheng Zhang in European Journal of Clinical Microbiology & Infectious Diseases
    Article 04 October 2023
Did you find what you were looking for? Share feedback.